KC

Knoll Capital Management

Description

Knoll Capital Management is a venture capital firm thats invests in firms focused in information technology sector.

Investor Profile

Knoll Capital Management has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (50%)
  • Post Ipo Equity (25%)
  • Series B (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Medical
  • Precision Medicine
  • Health Diagnostics
  • Neuroscience
  • Genetics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Knoll Capital Management frequently co-invest with?

Connecticut Innovations
North America, Connecticut, United States, Rocky Hill
Co-Investments: 2
Co-Investments: 2
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Aperture Venture Partners
North America, New York, United States, New York
Co-Investments: 2
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 2
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 2
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1
Venrock
North America, California, United States, Palo Alto
Co-Investments: 2
Aisling Capital
North America, New York, United States, New York
Co-Investments: 2

Which angels does Knoll Capital Management often collaborate with?

CI
North America, New York, United States, New York
Shared Deals: 1
Shared Deals: 2
GB
Europe, England, United Kingdom, London
Shared Deals: 2

What are some of recent deals done by Knoll Capital Management?

electroCore

Basking Ridge, New Jersey, United States

ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.

Health CareMedical DeviceTherapeutics
Series BNov 29, 2017
Amount Raised: $34,000,000
Exicure

Chicago, Illinois, United States

Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets.

BiotechnologyGeneticsLife ScienceTherapeutics
Series UnknownNov 6, 2017
Amount Raised: $11,200,000
Bristol-Myers Squibb

New York, New York, United States

Bristol-Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.

BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Post Ipo EquityFeb 21, 2017
Amount Raised: $80,000,000
Biohaven Pharmaceutical

New Haven, Connecticut, United States

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

BiotechnologyHealth CareHealth DiagnosticsNeurosciencePharmaceutical
Series UnknownNov 1, 2016
Amount Raised: $80,000,000